Israel - English - Ministry of Health

takeda israel ltd - lanthanum as carbonate hydrate - chewable tablets - lanthanum as carbonate hydrate 500 mg - lanthanum carbonate - lanthanum carbonate - fosrenol is indicated as a phosphate binding agent for use in the control of hyperphosphatemia in crf patients on haemodyalisis or continuous ambulatory peritoneal dialysis (capd).fosrenol is also indicated in adult patients with chronic kidney disease not on dialysis with serum phosphate levels > or = 1.78 mmol/l in whom a low phosphate diet alone is insufficient to control serum phosphate levels.

Israel - English - Ministry of Health

takeda israel ltd - lanthanum as carbonate hydrate - chewable tablets - lanthanum as carbonate hydrate 750 mg - lanthanum carbonate - lanthanum carbonate - fosrenol is indicated as a phosphate binding agent for use in the control of hyperphosphatemia in crf patients on haemodyalisis or continuous ambulatory peritoneal dialysis (capd).fosrenol is also indicated in adult patients with chronic kidney disease not on dialysis with serum phosphate levels > or = 1.78 mmol/l in whom a low phosphate diet alone is insufficient to control serum phosphate levels.

Israel - English - Ministry of Health

takeda israel ltd - lanthanum as carbonate hydrate - chewable tablets - lanthanum as carbonate hydrate 1000 mg - lanthanum carbonate - lanthanum carbonate - fosrenol is indicated as a phosphate binding agent for use in the control of hyperphosphatemia in crf patients on haemodyalisis or continuous ambulatory peritoneal dialysis (capd).fosrenol is also indicated in adult patients with chronic kidney disease not on dialysis with serum phosphate levels > or = 1.78 mmol/l in whom a low phosphate diet alone is insufficient to control serum phosphate levels.

Ireland - English - HPRA (Health Products Regulatory Authority)

shire pharmaceutical contracts ltd - lanthanum carbonate hydrate - tablets chewable - 500 milligram - drugs for treatment of hyperkalemia and hyperphosphatemia

Ireland - English - HPRA (Health Products Regulatory Authority)

shire pharmaceutical contracts ltd - lanthanum carbonate hydrate - tablets chewable - 250 milligram - drugs for treatment of hyperkalemia and hyperphosphatemia

Ireland - English - HPRA (Health Products Regulatory Authority)

shire pharmaceutical contracts ltd - lanthanum carbonate hydrate - tablets chewable - 1000 milligram - drugs for treatment of hyperkalemia and hyperphosphatemia

Ireland - English - HPRA (Health Products Regulatory Authority)

shire pharmaceutical contracts ltd - lanthanum carbonate hydrate - tablets chewable - 750 milligram - drugs for treatment of hyperkalemia and hyperphosphatemia

Ireland - English - HPRA (Health Products Regulatory Authority)

shire pharmaceutical contracts ltd - lanthanum carbonate hydrate - oral powder - 750 milligram - drugs for treatment of hyperkalemia and hyperphosphatemia

Ireland - English - HPRA (Health Products Regulatory Authority)

shire pharmaceutical contracts ltd - lanthanum carbonate hydrate - oral powder - 1000 milligram - drugs for treatment of hyperkalemia and hyperphosphatemia

Singapore - English - HSA (Health Sciences Authority)

takeda pharmaceuticals (asia pacific) pte. ltd. - lanthanum (as lanthanum carbonate hydrate 1908mg) - tablet, chewable - 1000mg - lanthanum (as lanthanum carbonate hydrate 1908mg) 1000mg